|
AUH expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.21589999999106E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.979260E-04 |
| Normal-vs-Stage2 |
5.390100E-02 |
| Normal-vs-Stage3 |
3.8160999999981E-05 |
| Normal-vs-Stage4 |
3.19610005128368E-09 |
| Stage1-vs-Stage2 |
4.955200E-01 |
| Stage1-vs-Stage3 |
7.809900E-02 |
| Stage1-vs-Stage4 |
5.72110000000015E-05 |
| Stage2-vs-Stage3 |
8.511700E-02 |
| Stage2-vs-Stage4 |
1.139450E-03 |
| Stage3-vs-Stage4 |
4.186000E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.66970000003985E-06 |
| Normal-vs-AfricanAmerican |
4.678400E-02 |
| Normal-vs-Asian |
5.004300E-04 |
| Caucasian-vs-AfricanAmerican |
3.619000E-01 |
| Caucasian-vs-Asian |
7.207200E-01 |
| AfricanAmerican-vs-Asian |
6.084200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.52830000000371E-05 |
| Normal-vs-Female |
5.53599999999488E-05 |
| Male-vs-Female |
7.712400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.426700E-04 |
| Normal-vs-Age(41-60Yrs) |
4.356600E-04 |
| Normal-vs-Age(61-80Yrs) |
2.42419999996191E-06 |
| Normal-vs-Age(81-100Yrs) |
6.302800E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.706200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.196200E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.873770E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.952200E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.511200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.412400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.417900E-04 |
| Classical-VS-Follicular |
1.828240E-02 |
| Classical-VS-Other |
8.740200E-01 |
| Classical-VS-Normal |
1.79176999999253E-05 |
| Tall-VS-Follicular |
1.88530000000409E-06 |
| Tall-VS-Other |
4.310300E-02 |
| Tall-VS-Normal |
1.29789999858687E-08 |
| Follicular-VS-Other |
5.299800E-01 |
| Follicular-VS-Normal |
1.016450E-01 |
| Other-VS-Normal |
1.056970E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.319700E-03 |
| Normal-vs-N1 |
8.78920000113581E-08 |
| N0-vs-N1 |
1.696300E-03 |
|
|
